These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8988747)

  • 1. Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma.
    Taube A; Lundell G
    Cancer; 1997 Jan; 79(1):190-1. PubMed ID: 8988747
    [No Abstract]   [Full Text] [Related]  

  • 2. Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.
    Cheng W; Ma C; Fu H; Li J; Chen S; Wu S; Wang H
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1353-60. PubMed ID: 23436920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma--a critique.
    Roos DE; Smith JG
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):493-5. PubMed ID: 10348276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH].
    Rosário PW
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):338-40. PubMed ID: 22911289
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
    Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
    Bal CS; Kumar A; Pant GS
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer.
    Doi SA; Woodhouse NJ
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):765-73. PubMed ID: 10848882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.
    Pacini F; Ladenson PW; Schlumberger M; Driedger A; Luster M; Kloos RT; Sherman S; Haugen B; Corone C; Molinaro E; Elisei R; Ceccarelli C; Pinchera A; Wahl RL; Leboulleux S; Ricard M; Yoo J; Busaidy NL; Delpassand E; Hanscheid H; Felbinger R; Lassmann M; Reiners C
    J Clin Endocrinol Metab; 2006 Mar; 91(3):926-32. PubMed ID: 16384850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation.
    Haugen BR
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3665-7. PubMed ID: 15292284
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma.
    Bal C; Padhy AK; Jana S; Pant GS; Basu AK
    Cancer; 1996 Jun; 77(12):2574-80. PubMed ID: 8640708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].
    Chebotareva ED; Shishkina VV
    Lik Sprava; 1997; (1):118-22. PubMed ID: 9221132
    [No Abstract]   [Full Text] [Related]  

  • 15. [The external radiotherapy of differentiated thyroid carcinoma].
    Sautter-Bihl ML; Heinze HG
    Dtsch Med Wochenschr; 1992 Apr; 117(17):665-8. PubMed ID: 1369745
    [No Abstract]   [Full Text] [Related]  

  • 16. [Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi].
    Kukulska A; Krajewska J; Roskosz J; Handkiewicz-Junak D; Jarzab M; Paliczka E; Puch Z; Wygoda Z; Gubała E; Jarzab B
    Endokrynol Pol; 2006; 57(4):374-9. PubMed ID: 17006839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimation.
    Jentzen W; Moldovan AS; Ruhlmann M; Görges R; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2015; 54(3):137-43. PubMed ID: 25987357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized equivalence trial to determine the optimum dose of iodine-131 for remnant ablation in differentiated thyroid cancer.
    Bal C; Chandra P; Kumar A; Dwivedi S
    Nucl Med Commun; 2012 Oct; 33(10):1039-47. PubMed ID: 22760303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
    De Klerk JM; Oyen WJ
    Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
    Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
    Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.